Serum Urokinase Plasminogen Activator as a Novel Biological Marker for COPD- A Review

Journal Title: Journal of Clinical and Diagnostic Research - Year 2019, Vol 13, Issue 7

Abstract

ABSTRACT Chronic Obstructive Pulmonary Disease (COPD), a progressive disease of the airways is associated with chronic inflammation of respiratory passages that leads to irreversible lung dysfunction and distinct morphological changes. The progressive increase in airflow limitation that is seen in COPD is associated with systemic inflammation with the development of extra-pulmonary complications like muscle atrophy, cachexia and osteoporosis. Several biomarkers like C-Reactive Protein (CRP), fibrinogen and Interleukin have been used as an adjunct tool to diagnose COPD. Soluble Urokinase Plasminogen Activator Receptor (suPAR) has been used as a diagnostic marker for congestive heart failure, sepsis, adult respiratory distress syndrome and acute exacerbation COPD. The present narrative review gives a brief overview on clinical significance of suPAR in the diagnosis and prognosis of COPD. The articles quoted in this review were taken from search engines like PubMed Central, Crossref, Web of Science and Google Scholar for articles published from 1991 to 2016, by using domain words like “COPD”, “suPAR”, “inflammation” and “prognosis”. The relevant references cited in these articles were also reviewed.

Authors and Affiliations

D Rekha, Priscilla Johnson, Subhasis Das, B Rajagopalan, GR Sathya

Keywords

Related Articles

Nutritional Intake in Low Body Mass Index (BMI) Males with Type 1 Diabetes and Fibrocalcific Pancreatic Diabetes: What are the Unmet Needs? A Cross-Sectional Study from a South Indian Tertiary Care Hospital

Introduction: There is paucity of data on the nutritional intake in low Body Mass Index (BMI) Asian Indians with diabetes. Aim: To study the difference in the nutrient intake pattern in low-BMI Type 1 Diabetes Mellitus (...

Pregnancy Induced Hypertension and Feto-Maternal Outcome in a Tertiary Care Hospital in Eastern India: A Prospective Study

ABSTRACT Introduction: Pregnancy Induced Hypertension (PIH) is known for its maternal and perinatal complications. Aim: To assess incidence of PIH and eclampsia in a tertiary care hospital and maternal and perinatal comp...

Cytological Diagnosis of Primary Cutaneous Aspergillosis Masquerading as Lipoma in a Known Case of Lepromatous Leprosy

Primary cutaneous aspergillosis is a rare disease, caused by organisms like Aspergillus flavus and Aspergillus fumigatus. Fine Needle Aspiration Cytology (FNAC) is a simple and well established tool for the diagnosis of...

The Effect of Hydro-Alcoholic Extraction of Valerian on Number and Morphology of Raphe Magnus Nucleus in Astrocytes in Rat Model

ABSTRACT Introduction: The valerian root extract has been used to treat sleep disorders, stress, depression, anxiety, muscle stiffness and tension. Astrocyte cells are involved in neural support, nutrition and protectio...

Effectiveness of Indian Diabetes Risk Score as a Screening Tool for Non-alcoholic Fatty Liver Disease: A Study from Anand, Gujarat, India

ABSTRACT Introduction: Non-alcoholic fatty liver disease (NAFLD) is widely prevalent in the Gujarati population and also shares risk factors with other Non-communicable diseases (NCDs) such as diabetes, obesity, and meta...

Download PDF file
  • EP ID EP606967
  • DOI 10.7860/JCDR/2019/41763.12979
  • Views 101
  • Downloads 0

How To Cite

D Rekha, Priscilla Johnson, Subhasis Das, B Rajagopalan, GR Sathya (2019). Serum Urokinase Plasminogen Activator as a Novel Biological Marker for COPD- A Review. Journal of Clinical and Diagnostic Research, 13(7), 1-4. https://europub.co.uk/articles/-A-606967